Elecsys® CK-MB What is the Test Kit?
Elecsys® CK-MB testcreatine kinaz MB is a advanced technology immunooassay test kit that allows the isolate of isothesis as quantitatively in human serum and plasma. Roche Diagnostics developed by this test, especially myokard infarction (heart attack) designed to be used as an aid to the diagnosis. Shake blood in case of damage to heart muscle cells CK-MB Isoenzyme is considered a reliable biochemical indicator of heart damage.
This test, in vitro diagnosis (IVDIt is suitable for use and is only a product that needs to be operated in professional laboratory conditions.
Measurement Principle of Test: ECLIA Technology
Elecsys® CK-MB test, Electrolymorphanism Imperfection (ECLIA) based on technology. This advanced technology platform provides reliable results by working with high precision and specificity. In the measuring process, CK-MB The complex is created using antibodies specific to the izoenzime and these complexes are detected by the signal of electro-chemiluminessance. Results are calculated automatically through Cobas e analyzers as quantitative.
Test Parameters:
- Measurement Type: Quantitative
- Sample Type: Human serum and plasma
- Method: ECLIA (Electrochemiluminescence Immunoassay)
- Clinical Use: Myokard enfarction test to help diagnose
Full compliance with Cobas e Analyzers
Elecsys® CK-MB test, Roche“High performance Cobas e series immunooassay analyzers optimized to work fully compatible. These analyzers offer integrated solutions that provide speed, accuracy and efficiency in laboratories.
Compatible Systems:
- Cobas e 411
- Cobas e 402
- Cobas e 601
- Cobas e 602
- Cobas e 801
With these devices Elecsys A complete synchronization between the test kites provides a high repetitiveness in the measurement results. In addition, integrated laboratory automation reduces operator errors by minimizing manual intervention.
CK-MB Why Measure? What is Clinical Importance?
CK-MB isolyzimi, mainly in the heart muscle a type of creatine kinase that is located in. When the heart muscle cells are damaged, this enzyme is mixed into the blood and measured the level heart attack or other heart damage used in the diagnosis of the situation.
CK-MB The test is often asked in the following cases:
- In patients applying emergency service with acute chest pain
- Myocard infarction (MI) Supporting the diagnosis
- Monitoring the recovery process after heart attack
- Other cardiac markers (especially Troponin)
CK-MBIn less than Troponin, it tends to rise and return to normal, so it can also be used in the detection of repetitive heart crises.
Advantages that Clinical Use Provides
Elecsys® CK-MB The test offers the following advantages to laboratories and healthcare professionals:
- High sensitivity early diagnosis
- Short analysis time with quick results
- Quantitative measurement better interpretation of the degree of heart damage
- ECLIA platform with superior repeatability and reliability
- Full automatic analysis saving time and work power
This test, especially emergency services, cardiology laboratories and provides an effective solution in health institutions with high-volume test centers.
Technical Specifications and Package Content
Elecsys® CK-MB The test is specially packaged for easy installation and stable use, integrated into laboratory systems.
Package Contents:
- CK-MB reagent cartridges
- Calibrator and controls
- User manual
- Barcode labels
Shelf Life and Storage:
- Storage Conditions: 2–8 °C
- Stability Time: From the date of production in unopened packaging 12 month
- After Opened Usage Time: After placing the device, it should be used in the recommended time (depending on the catalog information)
Legal Compliance and Regulations
Elecsys® CK-MB test kit, only in vitro diagnostic use Designed for professional health institutions and should be used in professional healthcare organizations. Test kit, CE Tags and, Roche Diagnostics’ is produced according to international quality management systems.
Warning:
- It is not suitable for use at home.
- Clinical evaluation is necessary before use for diagnosis purposes.
- It should be interpreted with other cardiac markers.
Why? Elecsys® CK-MB Test Kit Preferred?
- Roche Diagnostics quality and reliability
- High accuracy and low variation rate
- Full compatibility with Cobas e analyzers
- Quickly contribute to diagnosis in critical cases
- Long shelf life and stable performance
For both patient safety and operational efficiency in your laboratories Elecsys® CK-MB By opting for the test kit, you can be a step ahead in the diagnosis of the heart attack.
Where to Supply? Tilia Medical Assurance
Elecsys® CK-MB test kit, Roche Diagnosticśs advanced technology solutions are included in Turkey and regions Tilia Medical can be supplied with the assurance.
Tilia Medical, 2017 Founded in Turkey, Turkey is one of the leading solution providers of health sector in Europe and the Middle East. Our Company laboratory test kits, diagnostic devices, consumables and installation services specializes in areas.
Roche Diagnostics our team of qualified and experienced in products, Elecsys test kits It provides the supply of many high sensitivity diagnostic kites, primarily. There are also special logistic, technical support and device calibration services to your laboratories.
Why? Tilia Medical?
- Roche authorized product supply
- Fast delivery and wide stock
- Technical consulting and after-sales support
- ISO 9001 and CE Service to meet quality standards
